跳至主要内容
临床试验/NCT02352103
NCT02352103已完成3 期

The Impact of Retzius-sparing Approach for Robot-assisted Laparoscopic Radical Prostatectomy on Short-term Continence Recovery: Randomized Controlled Trial

Henry Ford Health System4 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2015年1月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
120
试验地点
4
主要终点
Urinary Continence Recovery

研究概览

简要总结

To assess and compare the short-term post-operative continence recovery rate in two cohorts of men undergoing Robot Assisted Radical Prostatectomy (RARP), each randomized to undergo RARP with Vattikuti Institute technique or Retzius sparing technique.

详细描述

Traditionally, RARP is performed using a trans-peritoneal technique that pass anteriorly to the bladder. This technique necessitates the dissection and/or manipulation of many structures, which might compromise post-operative urinary continence recovery. These structures include the pubo-prostatic ligament, Santorini plexus, neurovascular bundle, and veil of Aphrodite. Recently, a "Retzius-sparing" technique to perform RARP has beed described. This approach passes posteriorly to the bladder, through the space of Douglas, which should minimize the damaged to the aforementioned structure. Theoretically, the latter technique should improve post-operative urinary continence recovery. However, a randomized comparison between the "traditional" RARP and "Retzius-sparing" RARP is still lacking.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • All patients with newly diagnosed prostate cancer undergoing robotic-assisted radical prostatectomy at the Vattikuti Urology Institute (performed by single surgeon, MM) as the primary treatment modality
  • Be able to read and speak English and be able to provide written informed consent

排除标准

  • patients with high risk prostate cancer,defined as a biopsy Gleason score ≥8 and/or a pre-operative prostate specific antigen value ≥20 ng/ml.
  • evidence of clinical nodal involvement (cN1) or metastatic disease (M1)
  • patients participating in a competing study
  • patients with pre-operative urinary incontinence.

结局指标

主要结局

Urinary Continence Recovery

时间窗: One week after the removal of the suprapubic urinary catheter

24-hour pad weights

次要结局

  • Number of Participants With Urinary Continence Recovery(within 3 months from the intervention)
  • Number of Participants With Peri and Postoperative Complications(1-year median follow up)
  • Number of Participants Who Regained Potency Postoperatively (as Measured by Sexual Health Inventory for Men (SHIM) Score of 17 or Greater)(1-year median follow up)
  • Number of Participants Who Had Biochemical Recurrence (Post-operative Prostate-Specific Antigen (PSA) Value >=0.2 ng/ml)(1-year median follow up)
  • Post-operative Urinary Function and Urinary Function-related Quality of Life(Within 3 months from the intervention)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mani Menon

Director, Vattikuti Urology Institute

Henry Ford Health System

研究点 (4)

Loading locations...

相似试验